Skip to main content
. 2021 Sep 17;16(9):e0257705. doi: 10.1371/journal.pone.0257705

Fig 6. Stable docking mode of the selected ingredients obtained from AutoDock Vina docking simulations.

Fig 6

(A) Human ACE2. (B) Human TMPRSS2 model. Stable docking mode of test compounds is shown as CPK-colored tubes. The original crystal structure of the inhibitor is shown in black lines. A magenta sphere shows Zn2+ ion. Inhibitor-binding site located at 3 Å from all heavy atoms of the crystal inhibitor is shown in cyan color. Amino acid residues located at 3 Å from the inhibitor are shown using thin tubes with label. Hydrogen atoms are neglected.

HHS Vulnerability Disclosure